首页> 外文期刊>International Journal of Cancer =: Journal International du Cancer >A Nationwide Cohort Study on the risk of non‐gynecological cancers in women with surgically verified endometriosis
【24h】

A Nationwide Cohort Study on the risk of non‐gynecological cancers in women with surgically verified endometriosis

机译:全国范围的队列研究手术验证子宫内膜异位症的妇女非妇科癌症风险研究

获取原文
获取原文并翻译 | 示例
           

摘要

We assessed the association of surgically verified endometriosis and risk of non‐gynecological cancers according to the type of endometriosis (i.e., ovarian, peritoneal and deep infiltrating endometriosis). All diagnoses of endometriosis combined with relevant procedural codes were identified from the Finnish Hospital Discharge Register 1987–2012. Non‐gynecological cancers diagnosed after the endometriosis diagnosis were obtained from the Finnish Cancer Registry. The cohort of 49,933 women with surgically verified endometriosis and the sub‐cohorts of ovarian ( n = 23,210), peritoneal ( n = 20,187), and deep infiltrating ( n = 2,372) endometriosis were analyzed separately. The endometriosis cohort contributed 838,685 person‐years of follow‐up and the Finnish female population served as the reference cohort. The standardized incidence ratio (SIR) and 95% confidence interval (95%CI) was calculated for each cancer separately. The follow‐up ended at emigration, death or on the 31st of December 2014. The non‐gynecological cancer risk was not increased among women with endometriosis (SIR 1.03, 95%CI 0.98–1.08). Endometriosis was associated with an increased risk of thyroid cancer in the entire cohort (SIR 1.43, 95%CI 1.23–1.64) and in the sub‐cohorts of ovarian and peritoneal endometriosis. We found a decreased risk of mouth and pharynx cancer (SIR 0.60, 95%CI 0.41–0.80), and of pancreatic cancer (SIR 0.76, 95%CI 0.58–0.96). The incidence of basal cell carcinoma was elevated in the entire cohort (SIR 1.18, 95%CI 1.10–1.25) and in the sub‐cohorts of ovarian and peritoneal endometriosis. In conclusion, women with surgically verified endometriosis have an altered risk of only few non‐gynecological cancers.
机译:我们评估了手术验证的子宫内膜异位症和非妇科癌症的风险根据子宫内膜异位症(即,卵巢,腹膜和深浸润的子宫内膜异位症)。芬兰医院排放寄存器1987-2012鉴定了与相关程序码联合的子宫内膜异位症的所有诊断。诊断出在子宫内膜异位症诊断后诊断的非妇科癌症从芬兰癌症登记处获得。分别分别分别分析49,933名具有手术验证的子宫内膜异位症和卵巢子群(n = 20,187),腹膜(n = 20,187)和深浸润(n = 2,372)子宫内膜异位症的群体。子宫内膜异位症队列贡献了838,685人 - 年的后续行动,芬兰女性人口作为参考队列。分别为每种癌症计算标准化发生率比(SIR)和95%置信区间(95%CI)。随访结束于移民,死亡或2014年12月31日。患有子宫内膜异位症的妇女患有非妇科癌症风险(SIR 1.03,95%CI 0.98-1.08)。子宫内膜异位症与整个队列中的甲状腺癌的风险增加(1.43,95%CI 1.23-1.64)和卵巢和腹膜子宫内膜异位症的亚群。我们发现口腔和咽部癌症的风险降低(0.60,95%CI 0.41-0.80)和胰腺癌(SIR 0.76,95%CI 0.58-0.96)。基础细胞癌的发病率在整个队列中升高(1.18,95%CI 1.10-1.25)和卵巢和腹膜子宫内膜异位症的子群。总之,手术验证的子宫内膜异位症的女性只有少数非妇科癌症的风险发生了变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号